CITIC Securities: Turning point in the medical devices sector has arrived

NightAirdropper · 2026-03-28T14:23:00+00:00

Everyday AI Express, on March 26th, CITIC Construction Investment Research Report pointed out that the medical devices sector is approaching a turning point, and stocks with improved performance in 2026 have the opportunity for performance and valuation recovery. Focus on companies that are expected to accelerate growth in 2026 compared to 2025, which may achieve a double increase in performance and valuation in the future. For 2026, it is recommended to focus on investment opportunities related to performance recovery and overseas expansion in the A-share medical devices sector. In Hong Kong stocks, pay attention to the market effect brought by the listing of several high-quality medical device companies, as well as the opportunity to gradually realize profits and low valuation layouts of leading companies in various medical device segments.

NightAirdropper

2026-03-28 14:23:00

According to the AI news report from every day, on March 26, CITIC Securities pointed out that a turning point is coming for the medical device sector, with individual stocks showing opportunities for performance valuation recovery in 2026. Focus on companies that are expected to accelerate growth in 2026 compared to 2025, as they are likely to achieve a double increase in performance valuation in the future. In 2026, the A-share medical device sector is recommended to focus on investment opportunities related to performance recovery and international expansion, while in the Hong Kong stock market, attention should be paid to the sector effects brought by the listing of several high-quality medical device companies, as well as the gradual release of profits and undervalued layout opportunities by several leading companies in specific segments of the medical device industry.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes